BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

467 related articles for article (PubMed ID: 25634209)

  • 1. Interaction of BARD1 and HP1 Is Required for BRCA1 Retention at Sites of DNA Damage.
    Wu W; Nishikawa H; Fukuda T; Vittal V; Asano M; Miyoshi Y; Klevit RE; Ohta T
    Cancer Res; 2015 Apr; 75(7):1311-21. PubMed ID: 25634209
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HP1 regulates the localization of FANCJ at sites of DNA double-strand breaks.
    Wu W; Togashi Y; Johmura Y; Miyoshi Y; Nobuoka S; Nakanishi M; Ohta T
    Cancer Sci; 2016 Oct; 107(10):1406-1415. PubMed ID: 27399284
    [TBL] [Abstract][Full Text] [Related]  

  • 3. BARD1 reads H2A lysine 15 ubiquitination to direct homologous recombination.
    Becker JR; Clifford G; Bonnet C; Groth A; Wilson MD; Chapman JR
    Nature; 2021 Aug; 596(7872):433-437. PubMed ID: 34321663
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Class I histone deacetylase inhibitors inhibit the retention of BRCA1 and 53BP1 at the site of DNA damage.
    Fukuda T; Wu W; Okada M; Maeda I; Kojima Y; Hayami R; Miyoshi Y; Tsugawa K; Ohta T
    Cancer Sci; 2015 Aug; 106(8):1050-6. PubMed ID: 26053117
    [TBL] [Abstract][Full Text] [Related]  

  • 5. BGL3 lncRNA mediates retention of the BRCA1/BARD1 complex at DNA damage sites.
    Hu Z; Mi S; Zhao T; Peng C; Peng Y; Chen L; Zhu W; Yao Y; Song Q; Li X; Li X; Jia C; Pei H
    EMBO J; 2020 Jun; 39(12):e104133. PubMed ID: 32347575
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RNF168-mediated localization of BARD1 recruits the BRCA1-PALB2 complex to DNA damage.
    Krais JJ; Wang Y; Patel P; Basu J; Bernhardy AJ; Johnson N
    Nat Commun; 2021 Aug; 12(1):5016. PubMed ID: 34408138
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural requirements for the BARD1 tumor suppressor in chromosomal stability and homology-directed DNA repair.
    Laufer M; Nandula SV; Modi AP; Wang S; Jasin M; Murty VV; Ludwig T; Baer R
    J Biol Chem; 2007 Nov; 282(47):34325-33. PubMed ID: 17848578
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SIRT2 promotes BRCA1-BARD1 heterodimerization through deacetylation.
    Minten EV; Kapoor-Vazirani P; Li C; Zhang H; Balakrishnan K; Yu DS
    Cell Rep; 2021 Mar; 34(13):108921. PubMed ID: 33789098
    [TBL] [Abstract][Full Text] [Related]  

  • 9. H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids.
    Nakamura K; Saredi G; Becker JR; Foster BM; Nguyen NV; Beyer TE; Cesa LC; Faull PA; Lukauskas S; Frimurer T; Chapman JR; Bartke T; Groth A
    Nat Cell Biol; 2019 Mar; 21(3):311-318. PubMed ID: 30804502
    [TBL] [Abstract][Full Text] [Related]  

  • 10. BARD1 regulates BRCA1 apoptotic function by a mechanism involving nuclear retention.
    Fabbro M; Schuechner S; Au WW; Henderson BR
    Exp Cell Res; 2004 Aug; 298(2):661-73. PubMed ID: 15265711
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanisms of BRCA1-BARD1 nucleosome recognition and ubiquitylation.
    Hu Q; Botuyan MV; Zhao D; Cui G; Mer E; Mer G
    Nature; 2021 Aug; 596(7872):438-443. PubMed ID: 34321665
    [TBL] [Abstract][Full Text] [Related]  

  • 12. BRCA1 DNA-binding activity is stimulated by BARD1.
    Simons AM; Horwitz AA; Starita LM; Griffin K; Williams RS; Glover JN; Parvin JD
    Cancer Res; 2006 Feb; 66(4):2012-8. PubMed ID: 16489000
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DNA damage-induced BARD1 phosphorylation is critical for the inhibition of messenger RNA processing by BRCA1/BARD1 complex.
    Kim HS; Li H; Cevher M; Parmelee A; Fonseca D; Kleiman FE; Lee SB
    Cancer Res; 2006 May; 66(9):4561-5. PubMed ID: 16651405
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Negative feedback loop of BRCA1-BARD1 ubiquitin ligase on estrogen receptor alpha stability and activity antagonized by cancer-associated isoform of BARD1.
    Dizin E; Irminger-Finger I
    Int J Biochem Cell Biol; 2010 May; 42(5):693-700. PubMed ID: 20060929
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural insight into BRCA1-BARD1 complex recruitment to damaged chromatin.
    Dai L; Dai Y; Han J; Huang Y; Wang L; Huang J; Zhou Z
    Mol Cell; 2021 Jul; 81(13):2765-2777.e6. PubMed ID: 34102105
    [TBL] [Abstract][Full Text] [Related]  

  • 16. BRCA1 : BARD1 induces the formation of conjugated ubiquitin structures, dependent on K6 of ubiquitin, in cells during DNA replication and repair.
    Morris JR; Solomon E
    Hum Mol Genet; 2004 Apr; 13(8):807-17. PubMed ID: 14976165
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential modulation of BRCA1 and BARD1 nuclear localisation and foci assembly by DNA damage.
    Brodie KM; Henderson BR
    Cell Signal; 2010 Feb; 22(2):291-302. PubMed ID: 19796682
    [TBL] [Abstract][Full Text] [Related]  

  • 18. BRCA1 and BARD1 colocalize mainly in the cytoplasm of breast cancer tumors, and their isoforms show differential expression.
    Wiener D; Gajardo-Meneses P; Ortega-Hernández V; Herrera-Cares C; Díaz S; Fernández W; Cornejo V; Gamboa J; Tapia T; Alvarez C; Carvallo P
    Breast Cancer Res Treat; 2015 Oct; 153(3):669-78. PubMed ID: 26395808
    [TBL] [Abstract][Full Text] [Related]  

  • 19. BRCA1 recruitment to damaged DNA sites is dependent on CDK9.
    Nepomuceno TC; Fernandes VC; Gomes TT; Carvalho RS; Suarez-Kurtz G; Monteiro AN; Carvalho MA
    Cell Cycle; 2017 Apr; 16(7):665-672. PubMed ID: 28278048
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nuclear-cytoplasmic shuttling of BARD1 contributes to its proapoptotic activity and is regulated by dimerization with BRCA1.
    Rodriguez JA; Schüchner S; Au WW; Fabbro M; Henderson BR
    Oncogene; 2004 Mar; 23(10):1809-20. PubMed ID: 14647430
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.